Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02720211 · ClinicalTrials.gov registry record · NA
Spectacle Tints and Thin-Films for Migraine
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02720211 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 10 participants.
The verdict
NCT02720211, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Nearly all migraine sufferers report sensitivity to light during a headache and a significant proportion of sufferers report light sensitivity between attacks. Light is also a common trigger for migraine headaches. Spectacle lenses that have been treated with tints and spectacle lenses that have been treated with thin-films have both been shown to reduce light sensitivity and headache in patients with migraine. At this time, it is not clear which spectacle lens treatment is superior. The purpose of this trial is to determine if there's a significant, therapeutic advantage to either spectacle lens treatment. Both treatments could be a novel, non-invasive adjuvant in the treatment of migraine.
Interventions
- DEVICE Gray tinted spectacle lenses
- DEVICE Thin-Film spectacle lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02720211
The ClinicalTrials.gov registry entry for NCT02720211 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gray tinted spectacle lenses is the first listed.
NCT02720211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02720211 about?
NCT02720211 is a clinical study titled "Spectacle Tints and Thin-Films for Migraine". Nearly all migraine sufferers report sensitivity to light during a headache and a significant proportion of sufferers report light sensitivity between attacks. Light is also a common trigger for migraine headaches. Spectacle lenses that have been treated with tints and spectacle lenses that have bee...
What is the current status of trial NCT02720211?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2016-08. Estimated completion is 2018-11-06.
What interventions are being tested in trial NCT02720211?
The interventions under investigation include: Gray tinted spectacle lenses (DEVICE), Thin-Film spectacle lenses (DEVICE).
Who is sponsoring clinical trial NCT02720211?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.